ACETO Corp (ACET) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
ACETO Reports Fiscal 2016 First Quarter Results
November 5, 2015 5:00 PM ESTPORT WASHINGTON, N.Y., Nov. 5, 2015 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2016 ended September 30, 2015.
First Quarter Fiscal 2016 versus First Quarter Fiscal 2015
Net sales of $133.5 million versus $130.8 million, a 2.1% increase Gross profit of $34.6 million versus $27.7 million, a 25.1% increase Net income of $9.3 million versus $4.8 million, a 92.6% increase Diluted EPS of $0.32 versus $0.17, an 88.2% increase Non-GAAP Adjusted Net Income of $11.0 million versus $6.6 million, a 66.4%... More